Article
Tuning T-cell immunological synapse by modular DNA-Nanobody engagers for precision immunotherapy
2026-07-23
Abstract excerpt
Bispecific T-cell engagers (TCEs) are a promising class of cancer immunotherapies, but their clinical use is limited by toxicity and insufficient specificity. Tuning the T cell– tumor interface through engager architecture may address these drawbacks. To this end, we engineered hybrid constructs composed of two nanobodies targeting CD3 and the model tumor antigen HER2, respectively, connected by rigid DNA linkers...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8ae07b92-636a-5d3d-a58f-0b5913eb6ba6
- DOI
- 10.64898/2026.07.22.740045
